Paris-Saclay represents 15% of French research (in terms of the number of researchers) and 40% of employment in public and private research in the Greater Paris region.
Ultimately, it will represent 25% of French research.
paris-saclay
Driving the research of today to reinvent the health of tomorrow
In 2023, the Servier Research and Development Institute opened its doors in the cross-disciplinary innovation hub at Paris-Saclay. In a few years’ time, this scientific hub of excellence will be home to nearly 25% of all scientific research activities in France.
The idea is that Servier will be able to develop a more agile and open approach to R&D that centers even more closely around the patient to speed up the discovery of innovative therapeutic solutions.
The overriding aim of the Servier R&D Institute at Paris-Saclay is to combine the Group’s innovation potential with a powerful ecosystem and a center of scientific excellence. In choosing to integrate Paris-Saclay, Servier is also helping to drive momentum in the local economy and boosting the profile of French research.
2023
opening in 2023
45,000sqm
a building spanning
1,500
employees
110
able to accommodate up to 110 people at the start-up incubator
1,850sqm
a surface for the start-up incubator
Having established a presence in one of the most dynamic innovation communities in the world, Servier is taking advantage of a unique opportunity to establish new partnerships and increase synergies with institutional and private sector research bodies.
Our teams at Servier operate within a high-level community and the Group is in contact with a number of local institutions, such as CNRS, CEA, Paris-Saclay University and the École Polytechnique graduate school. It is also involved in organizing events such as SPRING Saclay, TEDxSaclay, and the Symposium de l’Université Paris-Saclay.
Ranked as one of the eight clusters for innovation worldwide, along with Silicon Valley, Beijing, Boston and Silicon Wadi in Israel, Paris-Saclay has top-tier international influence. The site is home to key names in research as well as international companies, start-ups and renowned universities such as Paris-Saclay University, the first French university included in the Shanghai ranking, where it broke into the Top 15.
Paris-Saclay represents 15% of French research (in terms of the number of researchers) and 40% of employment in public and private research in the Greater Paris region.
Ultimately, it will represent 25% of French research.
The start-up incubator at the Servier Research and Development Institute is unique in France. This new synergy between the momentum of young, future-facing companies and Servier’s pharmaceutical knowledge will therefore create unique conditions that will accelerate therapeutic research.
Spartners, the 1,850 sqm incubator, features laboratories with state-of-the-art equipment alongside specially designed offices to facilitate discussion, as well as reception and catering areas. BioLabs, the premier US-based network of incubators open to high-potential start-ups, oversees the day-to-day management at the facility, supply equipment, provide services, offer practical support, and organize events and programs specially designed for start-ups operating in the life sciences industry.
Spartners was designed with capacity for over 100 scientists —i.e., around 15 start-ups, which turnover every two years on average.
In line with its Corporate Social Responsibility (CSR) strategy, Servier decided to set a new benchmark with the Paris-Saclay R&D Institute when it comes to sustainability. The Group is aiming to obtain the BiodiverCity® label, alongside WELL Building Standard® and HQE certification, by developing a building that is both environmentally friendly and supports biodiversity.
5,000sqm
of on-the-ground green spaces
9,000sqm
of green roofs
100sqm
of community gardens
Photo credit: ©Martin Argyroglo